Nektar Therapeutics
NKTR
NKTR
145 hedge funds and large institutions have $79.3M invested in Nektar Therapeutics in 2023 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 27 increasing their positions, 49 reducing their positions, and 72 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
45% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 49
67% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 72
Holders
145
Holding in Top 10
–
Calls
$329K
Puts
$54K
Top Buyers
| 1 | +$9.34M | |
| 2 | +$5.33M | |
| 3 | +$4.02M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$3.93M |
| 5 |
D.E. Shaw & Co
New York
|
+$3.37M |
Top Sellers
| 1 | -$18.4M | |
| 2 | -$15.5M | |
| 3 | -$4.4M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$3.6M |
| 5 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
-$2.62M |